• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨质疏松症——1996年在瑞典能做且应该做些什么?瑞典骨质疏松症协会]

[Osteoporosis--what can and should be done in Sweden 1996? Swedish Osteoporosis Society].

作者信息

Ljunghall S

机构信息

Medicinkliniken, Akademiska, Uppsala.

出版信息

Nord Med. 1996 Dec;111(10):335-8.

PMID:8992463
Abstract

Very recently we have seen the advent of new approaches to the investigation, treatment and prevention of osteoporosis. Pending the results of large prospective studies, a Swedish panel of experts has attempted to appraise currently available scientific knowledge of osteoporosis and make recommendations. A summary of this appraisal includes advice on bone densitometry, and on the treatment and management of patients with suspected or verified osteoporosis. It is suggested that individually tailored physical activity should be a fundamental feature of prevention and treatment, and that women in the 50-70-year-old age group, and perhaps older women as well, should have a daily calcium intake of 1200 mg. Vitamin D supplementation is recommended for the elderly under institutional care who spend no time outdoors. Oestrogen replacement therapy should be considered as prophylaxis in women at greater risk-e.g., due to manifest heredity, early menopause, low body weight, heavy smoking, or low bone mass, and in patients at risk of secondary osteoporosis.

摘要

最近,我们看到了骨质疏松症调查、治疗和预防新方法的出现。在大型前瞻性研究结果出来之前,一个瑞典专家小组试图评估目前关于骨质疏松症的科学知识并提出建议。该评估总结包括有关骨密度测量以及疑似或确诊骨质疏松症患者的治疗和管理的建议。建议个性化定制的体育活动应成为预防和治疗的基本特征,50至70岁年龄组的女性,或许老年女性也一样,每日钙摄入量应为1200毫克。建议为没有户外活动时间的机构护理下的老年人补充维生素D。对于高危女性,如因明显遗传、早绝经、体重低、大量吸烟或骨量低以及有继发性骨质疏松症风险的患者,应考虑雌激素替代疗法作为预防措施。

相似文献

1
[Osteoporosis--what can and should be done in Sweden 1996? Swedish Osteoporosis Society].[骨质疏松症——1996年在瑞典能做且应该做些什么?瑞典骨质疏松症协会]
Nord Med. 1996 Dec;111(10):335-8.
2
Osteoporosis: new hope for the future.骨质疏松症:未来的新希望。
Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54.
3
Osteoporosis in women.女性骨质疏松症
Prim Care. 1997 Mar;24(1):27-36.
4
Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.骨质疏松症诊断与管理临床实践指南。加拿大骨质疏松症协会科学咨询委员会。
CMAJ. 1996 Oct 15;155(8):1113-33.
5
[The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].[激素替代疗法对绝经后女性骨密度的影响:取决于维生素D受体(VDR)和雌激素受体(ER)基因的多态性]
Ann Acad Med Stetin. 2003;49:111-30.
6
Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.绝经后骨质疏松症的管理:北美更年期协会立场声明
Menopause. 2002 Mar-Apr;9(2):84-101.
7
Osteoporosis management.骨质疏松症管理
Int J Fertil Womens Med. 1999 Sep-Oct;44(5):241-9.
8
Non-response to osteoporosis treatment.对骨质疏松症治疗无反应。
J Br Menopause Soc. 2004 Jun;10(2):76-80. doi: 10.1258/136218004774202409.
9
Osteoporosis: preventive strategies.骨质疏松症:预防策略
Int J Fertil Womens Med. 1998 Mar-Apr;43(2):56-64.
10
Osteoporosis: handy tools for detection, helpful tips for treatment.骨质疏松症:检测的实用工具,治疗的有益建议。
J Fam Pract. 2008 May;57(5):311-20.